Irbesartan And Hydrochlorothiazide
Product Images NDC 71335-1392
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71335-1392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1b (Irbehctz 02)
Figure 2a (Irbehctz 03)
This appears to be a fragment of a table or chart displaying results from two studies labeled as "Irbe/HCTZ Study V" and "Irbe/HCTZ Study VI". The numbers at the bottom likely pertain to baseline diastolic blood pressure measurements in millimeters of mercury (mmHg) for each study. Without additional context or data, no further useful description can be provided.*
Figure 2b (Irbehctz 04)
Chemical Structure (Irbehctz 05)
Chemical Structure (Irbehctz 06)
Figure 3 (Irbehctz 07)
Figure 4 (Irbehctz 08)
Lbl7133513922
This is a medication label for a Dachaged tablet manufactured by Buyant Ranch Prcpach Bunbank. The tablet is peach-colored and oval-shaped with the imprint "2875". It contains a combination of irbesartan and Hctz and is used to treat heart-related conditions. The tablet should be stored at room temperature between 20°-25°C (68°-77°F) and kept out of reach of children. The label includes dosage information and cautions to read the product label before use. NDC number 7133513921 is also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.